F-18 Florbetazine
- Generic Name
- F-18 Florbetazine
A Phase I Clinical Study on the Safety and Pharmacokinetics of [18F]Florbetazine Injection
- First Posted Date
- 2024-09-12
- Last Posted Date
- 2024-09-12
- Lead Sponsor
- HTA Co., Ltd.
- Target Recruit Count
- 28
- Registration Number
- NCT06593626
- Locations
- 🇨🇳
Chinese PLA General Hospital, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath